Europe (WHO region) vs Palau: New cases tested for RR-/MDR-TB
Europe (WHO region)
88.0%
in 2024
Palau
100.0%
in 2024
Europe (WHO region) rank
3rd
Palau rank
1st
New cases tested for RR-/MDR-TB over time
- Europe (WHO region)
- Palau
How they compare
Palau currently reports 100.0% against 88.0% in Europe (WHO region), a difference of 12.0%.
That makes Palau's figure about 1.1 times Europe (WHO region)'s.
The two have swapped places 4 times across 17 shared years of data; in 2005 it was Palau ahead.
Europe (WHO region) ranks 3rd and Palau ranks 1st of 11 groups.
Palau has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Europe (WHO region) | Palau | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 41.0% | 90.0% | 49.0% | Palau |
| 2010s | 84.6% | 94.4% | 9.8% | Palau |
| 2020s | 90.8% | 100.0% | 9.2% | Palau |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Europe (WHO region) or Palau?
- Palau, at 100.0% against 88.0% in Europe (WHO region) as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Europe (WHO region) and Palau?
- 12.0%, with Palau ahead.
- How many years of comparable data are there for Europe (WHO region) and Palau?
- 17 years are reported by both, from 2005 to 2024.
- How do Europe (WHO region) and Palau rank globally for new cases tested for rr-/mdr-tb?
- Europe (WHO region) ranks 3rd and Palau ranks 1st of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.